Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+Status

被引:16
|
作者
Lu, Hecheng [1 ,2 ]
Yin, Jiandong [2 ]
机构
[1] Northeastern Univ, Sch Med & Bioinformat Engn, Shenyang, Peoples R China
[2] China Med Univ, ShengJing Hosp, Dept Radiol, Shenyang, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
breast cancer; receiver operating characteristic; immunohistochemistry; magnetic resonance imaging; gene expression; IN-SITU HYBRIDIZATION; CONTRAST-ENHANCED MRI; NEOADJUVANT CHEMOTHERAPY; GENE AMPLIFICATION; MOLECULAR SUBTYPES; FEATURE-SELECTION; CANCER; HETEROGENEITY; EXPRESSION; FEATURES;
D O I
10.3389/fonc.2020.00543
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast tumor heterogeneity is related to risk factors that lead to aggressive tumor growth; however, such heterogeneity has not been thoroughly investigated. Purpose: To evaluate the performance of texture features extracted from heterogeneity subregions on subtraction MRI images for identifying human epidermal growth factor receptor 2 (HER2) 2+ status of breast cancers. Materials and Methods: Seventy-six patients with HER2 2+ breast cancer who underwent dynamic contrast-enhanced magnetic resonance imaging were enrolled, including 42 HER2 positive and 34 negative cases confirmed by fluorescence in situ hybridization. The lesion area was delineated semi-automatically on the subtraction MRI images at the second, fourth, and sixth phases (P-1, P-2, and P-3). A regionalization method was used to segment the lesion area into three subregions (rapid, medium, and slow) according to peak arrival time of the contrast agent. We extracted 488 texture features from the whole lesion area and three subregions independently. Wrapper, least absolute shrinkage and selection operator (LASSO), and stepwise methods were used to identify the optimal feature subsets. Univariate analysis was performed as well as support vector machine (SVM) with a leave-one-out-based cross-validation method. The area under the receiver operating characteristic curve (AUC) was calculated to evaluate the performance of the classifiers. Results: In univariate analysis, the variance from medium subregion at P-2 was the best-performing feature for distinguishing HER2 2+ status (AUC = 0.836); for the whole lesion region, the variance at P-2 achieved the best performance (AUC = 0.798). There was no significant difference between the two methods (P = 0.271). In the machine learning with SVM, the best performance (AUC = 0.929) was achieved with LASSO from rapid subregion at P-2; for the whole region, the highest AUC value was 0.847 obtained at P-2 with LASSO. The difference was significant between the two methods (P = 0.021). Conclusion: The texture analysis of heterogeneity subregions based on intratumoral regionalization method showed potential value for recognizing HER2 2+ status in breast cancer.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer
    Cuadros, M.
    Talavera, P.
    Lopez, F. J.
    Garcia-Perez, I.
    Blanco, A.
    Concha, A.
    PATHOBIOLOGY, 2010, 77 (01) : 38 - 45
  • [32] A nomogram for predicting the HER2 status of circulating tumor cells and survival analysis in HER2-negative breast cancer
    Yang, Yuqin
    Li, Liudan
    Tian, Wenjing
    Qiao, Zhen
    Qin, Qi
    Su, Liqian
    Li, Peiqiu
    Chen, Weirong
    Zhao, Hong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] MRI-based vector radiomics for predicting breast cancer HER2 status and its changes after neoadjuvant therapy
    Zhang, Lan
    Cui, Quan-Xiang
    Zhou, Liang-Qin
    Wang, Xin-Yi
    Zhang, Hong-Xia
    Zhu, Yue-Min
    Sang, Xi-Qiao
    Kuai, Zi-Xiang
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2024, 118
  • [34] Simultaneous Analysis of HER2 Gene and Protein on a Single Slide Facilitates HER2 Testing of Breast and Gastric Carcinomas
    Hirschmann, Astrid
    Lamb, Tiffany Ann
    Marchal, Georges
    Padilla, Mary
    Diebold, Joachim
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (06) : 837 - 844
  • [35] 2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France
    Franchet, Camille
    Djerroudi, Lounes
    Maran-Gonzalez, Aurelie
    Abramovici, Olivia
    Antoine, Martine
    Becette, Veronique
    Berghian, Anca
    Blanc-Fournier, Cecile
    Brabencova, Eva
    Charafe-Jauffret, Emmanuelle
    Chenard, Marie-Pierre
    Dauplat, Marie-Melanie
    Delree, Paul
    Duprez-Paumier, Raphaelle
    Fleury, Clemence
    Ghnassia, Jean-Pierre
    Haudebourg, Juliette
    Leroux, Agnes
    MacGrogan, Gaetan
    Mathieu, Marie-Christine
    Michenet, Patrick
    Penault-Llorca, Frederique
    Poulet, Bruno
    Robin, Yves Marie
    Roger, Pascal
    Russ, Elisabeth
    Tixier, Lucie
    Treilleux, Isabelle
    Valent, Alexander
    Verriele, Veronique
    Vincent-Salomon, Anne
    Arnould, Laurent
    Lacroix-Triki, Magali
    ANNALES DE PATHOLOGIE, 2021, 41 (06) : 507 - 520
  • [36] HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
    Kurozumi, Sasagu
    Padilla, Mary
    Kurosumi, Masafumi
    Matsumoto, Hiroshi
    Inoue, Kenichi
    Horiguchi, Jun
    Takeyoshi, Izumi
    Oyama, Tetsunari
    Ranger-Moore, Jim
    Allred, D. Craig
    Dennis, Eslie
    Nitta, Hiroaki
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 99 - 111
  • [37] Comparison of Multi-resolution Analysis Patterns for Texture Classification of Breast Tumors Based on DCE-MRI
    Tzalavra, Alexia
    Dalakleidi, Kalliopi
    Zacharaki, Evangelia I.
    Tsiaparas, Nikolaos
    Constantinidis, Fotios
    Paragios, Nikos
    Nikita, Konstantina S.
    MACHINE LEARNING IN MEDICAL IMAGING, MLMI 2016, 2016, 10019 : 296 - 304
  • [38] Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab
    Lee, Hee Jin
    Kim, Joo Young
    Park, So Yeon
    Park, In Ah
    Song, In Hye
    Yu, Jong Han
    Ahn, Jin-Hee
    Gong, Gyungyub
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (04) : 570 - 578
  • [39] Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
    Braman, Nathaniel M.
    Etesami, Maryam
    Prasanna, Prateek
    Dubchuk, Christina
    Gilmore, Hannah
    Tiwari, Pallavi
    Pletcha, Donna
    Madabhushi, Anant
    BREAST CANCER RESEARCH, 2017, 19
  • [40] Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer
    Fan, Ming
    Zhang, Peng
    Wang, Yue
    Peng, Weijun
    Wang, Shiwei
    Gao, Xin
    Xu, Maosheng
    Li, Lihua
    EUROPEAN RADIOLOGY, 2019, 29 (08) : 4456 - 4467